Hualan Bio execs complete share buyback, exceeding minimum target

Hualan Biological Engineering (SZSE:002007) announced the completion of its share repurchase program. Executives, including the Chairman, actual controller, select directors, and senior management, bought back a total of 1,495,700 shares, exceeding the minimum target of 1,220,000 shares. The buyback, conducted through open market purchases between July 8, 2024, and January 8, 2025, represents 0.08% of the company's total share capital. Chairman An Kang purchased the largest portion, adding 1,260,000 shares to his holdings. The company cited confidence in future growth and long-term value as the motivation behind the repurchases.